Document is current
Any future updates will be listed below
-
Authors
Bohacova, Klara https://orcid.org/0009-0006-3939-2349
Nahacka, Zuzana https://orcid.org/0000-0003-0477-2764
Dudova, Jana https://orcid.org/0009-0002-0765-2901
Kovarova, Jaromira
Rohlena, Jakub https://orcid.org/0000-0001-5427-6502
Rennerova, Michaela
Kasperova, Barbora Judita https://orcid.org/0000-0003-4578-1093
Stursa, Jan
Werner, Lukas
Haluzik, Martin https://orcid.org/0000-0002-0201-6888
Neuzil, Jiri https://orcid.org/0000-0002-2478-2460
Hubackova, Sona Stemberkova https://orcid.org/0000-0002-3454-6840
- License Information
-
More Information
Article History
Received: 28 November 2024
Revised: 4 April 2025
Accepted: 24 April 2025
First Online: 8 May 2025
Competing interests
: JN, JS and LW are co-owners of MitoTax s.r.o. and the MitoTam intellectual property. SSH, JN, JS and LW are co-inventors of MitoTam as a senolytic agent. JN, JS and LW are also co-inventors of MitoTam as an oncolytic agent. Other authors declare no conflict of interest.
: Animal experiments were performed in agreement with the Animal Protection Law of the Czech Republic and were approved by the Ethics Committee of the Institute of Molecular Genetics, Prague, Czech Republic and by the Ministry of Health, Czech Republic.
